Anais Boulai
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancer.
Journal: Cell reports. Medicine
Published: February 20, 2025
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial.
Journal: Nature communications
Published: June 20, 2024
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
Journal: Genome medicine
Published: November 30, 2020
Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma.
Journal: The New England journal of medicine
Published: September 20, 2018
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
Journal: International journal of cancer
Published: September 19, 2018
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
Journal: Journal of hematology & oncology
Published: July 26, 2018
Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency.
Journal: The Journal of experimental medicine
Published: April 02, 2018
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Journal: Breast cancer research : BCR
Published: February 20, 2018
Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Journal: The Journal of allergy and clinical immunology
Published: July 18, 2016
Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
Journal: Journal of hepatology
Published: June 11, 2016
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.
Journal: Oncoimmunology
Published: October 17, 2013
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.
Journal: Cancer cell
Published: July 10, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026